Chinese authorities list New Year’s resolutions
HONG KONG – After a rocky year for many biopharma companies in China hit hard by bribery investigations companies may find some hopeful points in the overall trend of stricter supervision and punishment in the government’s list of priorities for health care enforcement.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter